Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bipin Nepal

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Asian Journal of Transfusion Science|June 25, 2026
Blood transfusion services in Nepal: An overviewPurshotam Paudel, Bipin Nepal
BMJ Open|March 10, 2026
Prevalence of ABO and Rh blood groups among individuals attending a tertiary care hospital in Nepal: a retrospective cross-sectional studyArun Bahadur Chand, Bindu Sen, Jenish Khadka, et al.
Clinical Case Reports|April 6, 2021
Combination of convalescent plasma therapy and repurposed drugs to treat severe COVID-19 patient with multimorbiditySanta Kumar Das, Kamal Ranabhat, Suraj Bhattarai, et al.
Open Forum Infectious Diseases|August 25, 2021
Experience of Treating COVID-19 With Remdesivir and Convalescent Plasma in a Resource-Limited Setting: A Prospective, Observational StudyJanak Koirala, Pradip Gyanwali, Robert B Gerzoff, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Asian Journal of Transfusion Science|June 25, 2026
Blood transfusion services in Nepal: An overviewPurshotam Paudel, Bipin Nepal
BMJ Open|March 10, 2026
Prevalence of ABO and Rh blood groups among individuals attending a tertiary care hospital in Nepal: a retrospective cross-sectional studyArun Bahadur Chand, Bindu Sen, Jenish Khadka, et al.
Clinical Case Reports|April 6, 2021
Combination of convalescent plasma therapy and repurposed drugs to treat severe COVID-19 patient with multimorbiditySanta Kumar Das, Kamal Ranabhat, Suraj Bhattarai, et al.
Open Forum Infectious Diseases|August 25, 2021
Experience of Treating COVID-19 With Remdesivir and Convalescent Plasma in a Resource-Limited Setting: A Prospective, Observational StudyJanak Koirala, Pradip Gyanwali, Robert B Gerzoff, et al.
Pageof 1